Biotronik performs first US implant of LivIQ leadless pacemaker

On June 8, 2026, Biotronik announced the first U.S. implant of its LivIQ leadless pacemaker as part of the BIO-LivIQ global pivotal clinical trial. The device uses a novel far-field sensing scheme to electrically detect atrial activity and thus enable a single-device VDD mode. According to Biotronik, this sensing approach supports AV synchrony across a [ ]